PracticeVideosBlogFlashcardsEspañol
All Practice Exams

Free Practice Questions for Egyptian Board Family Medicine

Exam-style questions and explanations by OpenExamPrep.

✓ No registration✓ No credit card
100+ Questions
100% Free

Loading practice questions...

Same family resources

Explore More Egyptian Board Specialty Certifications (البورد المصري)

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

Egyptian Board — Anesthesia (Part 1 & 2)

Practice Questions

Egyptian Board — Cardiology (Part 1 & 2)

Practice Questions

Egyptian Board — Clinical Infectious Diseases (Part 1 & 2)

Practice Questions

Egyptian Board — Clinical Oncology (Part 1 & 2)

Practice Questions

Egyptian Board — Clinical Pathology (Part 1 & 2)

Practice Questions

Egyptian Board — Critical Care (Part 1 & 2)

Practice Questions
Exam Review

Key Facts: Egyptian Board Family Medicine Exam

100

High-Yield Practice MCQs

OpenExamPrep

Law 12/2022

EHC Founding Legislation

Official Gazette

Part 1, 2 & 3

Board Examination Stages

EHC Regulations

Angoff/Hofstee

Standard-Setting Methodology

EHC Examination Board

The Egyptian Board in Family Medicine (EHC-EB-FM) is the definitive national postgraduate qualification under the Egyptian Health Council (Law 12/2022). The qualification comprises written Part 1 (epidemiology, biostatistics, preventive medicine, pharmacology; March/August), written Part 2 (clinical primary care, chronic disease management, maternal-child health, UHIS protocols; April/September), and clinical Part 3 (OSCE consultation stations; Dec/Jan). Psychometric cut scores are determined by Angoff and Hofstee standard setting. This practice bank provides 100 high-yield MCQs with detailed rationales across Part 1 and Part 2 written domains.

Sample Egyptian Board Family Medicine Practice Questions

Try these sample questions to review concepts for the Egyptian Board Family Medicine exam. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A community screening initiative for type 2 diabetes mellitus in an asymptomatic rural population with a low disease prevalence (4%) utilizes a rapid point-of-care capillary blood glucose test with 90% sensitivity and 90% specificity. If an asymptomatic individual tests positive, what is the most significant clinical consequence of the low prevalence on the diagnostic utility of this test result?
A.The positive predictive value will be markedly lower than the test specificity, yielding a high proportion of false-positive results.
B.The sensitivity of the screening test will decrease substantially because prevalence alters intrinsic test sensitivity.
C.The negative predictive value of the test will decrease, resulting in many missed cases among those who test negative.
D.The likelihood ratio positive (LR+) will drop below 1.0, rendering the test clinically incapable of ruling in disease.
Explanation: Predictive values are highly dependent on disease prevalence in the target population. In low-prevalence populations, even screening tests with high sensitivity and specificity (e.g., 90%) yield a low positive predictive value (PPV), meaning that a substantial proportion of positive test results are false positives requiring confirmatory diagnostic testing. In contrast, sensitivity and specificity are intrinsic properties of the test and remain independent of prevalence.
2A new diagnostic clinical rule for acute streptococcal pharyngitis evaluated in a family medicine practice demonstrates a sensitivity of 80% and a specificity of 90%. What is the positive likelihood ratio (LR+) of this clinical rule, and what does it indicate regarding clinical probability?
A.LR+ is 0.89, indicating that a positive test result moderately decreases the probability of disease.
B.LR+ is 8.0, indicating that a positive test result moderately increases the post-test probability of disease.
C.LR+ is 1.13, indicating that a positive test result has negligible impact on pre-test probability.
D.LR+ is 7.2, indicating that a positive test result confirms the definitive diagnosis without microbiological testing.
Explanation: The positive likelihood ratio is calculated as Sensitivity / (1 - Specificity). In this case, LR+ = 0.80 / (1 - 0.90) = 0.80 / 0.10 = 8.0. An LR+ between 5 and 10 generates a moderate, clinically meaningful shift from pre-test to post-test probability, supporting targeted antibiotic decision-making.
3A family physician is planning an epidemiological investigation to determine whether occupational pesticide exposure among greenhouse agricultural workers in the Nile Delta is associated with an increased long-term incidence of peripheral neuropathy. The exposure is rare in the general community, but high in this specific workforce. Which epidemiological study design is most methodologically efficient and robust for this objective?
A.A cross-sectional survey assessing current exposure and prevalent symptoms simultaneously.
B.A retrospective case-control study selecting patients with established peripheral neuropathy.
C.A prospective cohort study comparing exposed agricultural workers with an unexposed control cohort.
D.An ecological study comparing regional pesticide sales figures with district hospital admission logs.
Explanation: A prospective cohort study is the optimal design when investigating rare or specific occupational exposures, as individuals are classified by their known exposure status at baseline and followed prospectively to measure the direct incidence of outcomes over time. Cohort studies establish clear temporal sequence and permit direct calculation of relative risk (RR) and incidence rates.
4In an analytical case-control study investigating the relationship between heavy shisha (waterpipe) smoking and bladder carcinoma, investigators report an odds ratio (OR) of 3.2 (95% CI: 2.1–4.8). Under which of the following epidemiologic conditions does this calculated odds ratio best approximate the true relative risk (RR)?
A.When the exposure is extremely common in the control population (> 50%).
B.When the study controls are matched to cases by multiple demographic confounding variables.
C.When the statistical test of association reaches a p-value of less than 0.001.
D.When the incidence of the disease in the study population is low (rare disease assumption, typically < 5–10%).
Explanation: The odds ratio (OR) closely approximates the relative risk (RR) only under the 'rare disease assumption', which occurs when the incidence or cumulative prevalence of the condition in the studied population is low (generally less than 5% to 10%). When disease incidence is high, the odds ratio progressively overestimates the true relative risk.
5An observational study evaluating the association between regular physical activity and ischemic heart disease finds a crude relative risk of 0.60. Upon stratification by age (< 50 years vs >= 50 years), the stratum-specific relative risk is 0.85 in younger patients and 0.86 in older patients. How should the investigator interpret the influence of age on this observed relationship?
A.Age is a confounder, because the stratum-specific estimates are similar to each other but notably different from the crude estimate.
B.Age is an effect modifier, because the crude estimate differs significantly from the underlying true population effect.
C.Age is an intermediate step on the causal pathway between physical activity and coronary atherosclerosis.
D.Age exhibits non-differential misclassification bias, leading to artificial attenuation of the relative risk.
Explanation: A confounding variable distorts the measure of association between exposure and disease. Confounding is identified when the crude estimate differs substantially from the stratum-specific estimates (crude RR = 0.60 vs stratum RRs = 0.85 and 0.86), while the stratum-specific estimates remain essentially homogeneous (similar to each other). If the stratum-specific estimates differed significantly from one another, age would instead be an effect modifier.
6A researcher conducts a case-control study within a tertiary university hospital in Cairo to examine whether chronic non-steroidal anti-inflammatory drug (NSAID) use is associated with peptic ulcer perforation. Both cases (perforated ulcer) and controls (osteoarthritis without ulcer) are recruited solely from inpatient hospital admissions. Which specific form of selection bias is most likely to distort the findings of this study?
A.Hawthorne effect, where subjects modify behavior as a consequence of being observed.
B.Berkson's bias (admission rate bias), resulting from differential hospitalization rates among individuals with multiple concurrent conditions.
C.Neyman's bias (prevalence-incidence bias), resulting from late inclusion of long-term survivors.
D.Attrition bias, caused by unequal loss to follow-up over extended observation periods.
Explanation: Berkson's bias (admission rate bias) is a classic selection bias that occurs in hospital-based case-control studies when hospitalized patients are selected as both cases and controls. Because individuals with both the exposure and illness (or comorbid conditions requiring NSAIDs) have higher probability of hospital admission than those in the community, the hospital-based odds ratio does not reflect the true population association.
7In a 5-year randomized controlled trial of high-intensity statin therapy versus placebo for secondary prevention of major adverse cardiovascular events (MACE) in primary care, the event rate was 15% in the placebo group and 10% in the statin group. What is the Number Needed to Treat (NNT) over 5 years to prevent one MACE?
A.3
B.5
C.20
D.33
Explanation: The Number Needed to Treat (NNT) is calculated as the inverse of the Absolute Risk Reduction (ARR): NNT = 1 / ARR. Here, ARR = Event Rate_Control - Event Rate_Intervention = 0.15 - 0.10 = 0.05 (or 5%). Thus, NNT = 1 / 0.05 = 20. This indicates that treating 20 patients with high-intensity statin therapy for 5 years prevents 1 cardiovascular event.
8In designing a primary care randomized trial testing a lifestyle counseling module for metabolic syndrome, the investigators set the significance level alpha at 0.05 and the statistical power at 80%. What is the exact definition of statistical power in this trial context?
A.The probability of rejecting the null hypothesis when the null hypothesis is actually true (Type I error).
B.The probability of failing to reject the null hypothesis when a true difference exists (Type II error).
C.The probability that an observed positive clinical finding represents a true biological effect in the population.
D.The probability of correctly rejecting the null hypothesis when a true difference of specified magnitude exists (1 - beta).
Explanation: Statistical power is defined as 1 - beta, representing the probability that a study will detect a statistically significant difference between study arms when a true difference of specified magnitude actually exists (correctly rejecting a false null hypothesis). A power of 80% means there is an 80% chance of detecting the true effect and a 20% risk of a false-negative result (Type II error).
9A newly introduced screening test for early-stage asymptomatic colorectal carcinoma detects lesions an average of 3 years before clinical symptoms manifest. Five-year survival measured from the time of diagnosis increases from 40% to 70%, but the actual chronological age at death of screened patients remains unchanged compared with unscreened controls. Which epidemiological bias explains this phenomenon?
A.Lead-time bias, where earlier diagnosis artificially lengthens measured survival time without prolonging life.
B.Length-time bias, where screening disproportionately detects slow-growing, less aggressive tumors.
C.Overdiagnosis bias, where subclinical lesions that would never cause clinical harm are identified.
D.Observer expectancy bias, where clinicians systematically document outcomes more favorably in screened cohorts.
Explanation: Lead-time bias occurs when screening identifies a disease earlier in its natural history (advancing the point of diagnosis) without altering the biological course of the illness or extending chronological survival. Consequently, survival measured from diagnosis appears longer simply because the diagnostic starting point was moved forward in time, even though mortality occurs at the exact same age.
10In a randomized clinical trial comparing an oral antihypertensive regimen to standard monotherapy, 15% of patients in the intervention arm discontinued therapy prematurely due to mild side effects and switched back to usual care. In evaluating trial outcomes, the principal investigators analyze all subjects according to their initial randomized assignment regardless of protocol adherence. What is the fundamental rationale for this intention-to-treat (ITT) approach?
A.It maximizes statistical power by artificially reducing between-group variance.
B.It preserves the prognostic balance achieved by baseline randomization and prevents attrition-related confounding.
C.It isolates the pure biological efficacy of the pharmacological agent under ideal adherence conditions.
D.It eliminates the necessity for blinding patients and investigators during follow-up assessments.
Explanation: The primary principle of an Intention-to-Treat (ITT) analysis is that all randomized participants are analyzed in the groups to which they were initially assigned, regardless of non-compliance, protocol deviations, or dropout. This methodology preserves the prognostic baseline balance established by randomization, avoids attrition bias, and provides an unbiased estimate of real-world clinical effectiveness.

About the Egyptian Board Family Medicine Exam

The Egyptian Board in Family Medicine (البورد المصري في طب الأسرة) is the official national postgraduate specialty qualification in family medicine established under the Egyptian Health Council (Law No. 12 of 2022 and Prime Ministerial Decree No. 3798 of 2023). Family medicine is the central pillar of Egypt's Universal Health Insurance System (UHIS / منظومة التأمين الصحي الشامل), positioning family physicians as the primary gatekeepers and coordinators of comprehensive healthcare at accredited Primary Healthcare Units (PHUs). The board certification pathway comprises three components: Part 1 (written MCQ assessing basic epidemiology, biostatistics, behavioral sciences, and clinical pharmacology); Part 2 (written MCQ evaluating comprehensive ambulatory clinical medicine, chronic illness protocols, maternal-child health, and UHIS clinical pathways); and Part 3 (a clinical OSCE assessing consultation communication, clinical examination, and procedural competencies). Please note: Part Three is a practical clinical OSCE; this question bank serves as an English-language MCQ study aid specifically curated for Part 1 and Part 2 written examination preparation.

Exam sponsor: Egyptian Health Council (EHC) — Egyptian Board. The requirements and fees below concern the certification or admission exam, separate from our free practice resources.

Assessment

The Egyptian Board Family Medicine certification is governed by Law No. 12 of 2022 and Prime Ministerial Decree No. 3798 of 2023 under the Egyptian Health Council. It consists of three standalone stages: Part 1 (written MCQ covering basic medical sciences: epidemiology, biostatistics, primary care behavioral science, preventive medicine principles, and clinical pharmacology, held twice annually in March and August); Part 2 (written MCQ covering clinical primary care: chronic disease management including hypertension, diabetes, and dyslipidemia, maternal and child health, geriatrics, outpatient dermatology, primary mental health, counseling, and Universal Health Insurance System [UHIS] guidelines in Egypt, held twice annually in April and September); and Part 3 (clinical examination consisting of Objective Structured Clinical Examinations [OSCE], consultation skills stations, and simulated clinical encounters, held in December and January). Note: This question bank is an English-language study aid focusing on Part 1 and Part 2 written examination competencies.

Time Limit

Varies by examination part

Passing Score

Set by psychometric standard-setting (Angoff/Hofstee method); no fixed percentage published

Exam / Certification Fees

Prescribed by Egyptian Health Council executive regulations (in Egyptian Pounds / EGP)

Exam sponsor website

Fees, eligibility, and exam policies can change. Confirm them with the exam sponsor before applying or paying.

Our practice resources: topics covered

We aim to reflect publicly available exam outlines and topic information in our study resources. Coverage, format, and difficulty may differ from the actual exam, and we cannot guarantee that every detail is accurate or current. Confirm exam requirements, fees, and policies with the official exam sponsor.

15%

Epidemiology, Biostatistics & Research Methods

Screening test validity (sensitivity, specificity, PPV, NPV, likelihood ratios), observational and experimental study designs, bias, confounding, and evidence-based clinical decision-making.

15%

Preventive Medicine, Immunization & Screening

Egyptian Expanded Program on Immunization (EPI), routine and high-risk adult vaccination, national cancer screening pathways (breast, cervical, colorectal, hepatocellular carcinoma), and public health initiatives (100 Million Healthy Lives).

12%

Primary Care Behavioral Sciences & Communication

Biopsychosocial model, patient-centered consultation (Calgary-Cambridge framework), family assessment (genograms, family APGAR), SPIKES bad news delivery, and motivational interviewing for lifestyle change.

12%

Clinical Pharmacology in Primary Healthcare

Pharmacokinetics across special populations (geriatrics, renal impairment), clinically significant drug interactions, antimicrobial stewardship in outpatient care, Beers criteria, and medication safety.

26%

Chronic Disease Management in Primary Care

Clinical guidelines for hypertension, type 2 diabetes mellitus, dyslipidemia, chronic obstructive pulmonary disease (COPD), asthma, ischemic heart disease, heart failure, and thyroid disorders.

20%

Maternal-Child Health, Outpatient Specialties & UHIS Regulations

Routine antenatal care, well-child developmental milestones, outpatient pediatric illnesses, common dermatological conditions, primary mental healthcare (depression, anxiety), geriatric syndromes, and Egyptian Universal Health Insurance System (UHIS) gatekeeping and GAHAR accreditation standards.

Preparing for the Egyptian Board Family Medicine Exam

What You Need to Know

  • Passing score: Set by psychometric standard-setting (Angoff/Hofstee method); no fixed percentage published
  • Assessment: The Egyptian Board Family Medicine certification is governed by Law No. 12 of 2022 and Prime Ministerial Decree No. 3798 of 2023 under the Egyptian Health Council. It consists of three standalone stages: Part 1 (written MCQ covering basic medical sciences: epidemiology, biostatistics, primary care behavioral science, preventive medicine principles, and clinical pharmacology, held twice annually in March and August); Part 2 (written MCQ covering clinical primary care: chronic disease management including hypertension, diabetes, and dyslipidemia, maternal and child health, geriatrics, outpatient dermatology, primary mental health, counseling, and Universal Health Insurance System [UHIS] guidelines in Egypt, held twice annually in April and September); and Part 3 (clinical examination consisting of Objective Structured Clinical Examinations [OSCE], consultation skills stations, and simulated clinical encounters, held in December and January). Note: This question bank is an English-language study aid focusing on Part 1 and Part 2 written examination competencies.
  • Time limit: Varies by examination part
  • Exam / certification fees: Prescribed by Egyptian Health Council executive regulations (in Egyptian Pounds / EGP) Official sources

Using Our Practice Resources

  • Work through all 100 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

Egyptian Board Family Medicine: Suggested Study Strategy

1Focus systematically on 2x2 epidemiology contingency tables, calculations of sensitivity, specificity, positive/negative predictive values, and likelihood ratios.
2Review the official Egyptian Expanded Program on Immunization (EPI) schedule from birth through 18 months, including bOPV, IPV, pentavalent, and MMR vaccine timings.
3Master the stepped management algorithms for hypertension (ESH/ISH/Egyptian guidelines) and type 2 diabetes mellitus (ADA/EASD/Egyptian NCD protocols) including cardiorenal protective agents (SGLT2i, GLP-1 RA).
4Understand the statutory structure of Egypt's Universal Health Insurance System (UHIS Law 2/2018), the tri-partite division (UHIA, GAHAR, EHA), and the GAHAR primary healthcare accreditation requirements.

Frequently Asked Questions

What is the examining body for the Egyptian Board in Family Medicine?

The Egyptian Board is administered by the Egyptian Health Council (EHC / المجلس الصحي المصري), established pursuant to Law No. 12 of 2022 and Prime Ministerial Decree No. 3798 of 2023 as the unified national authority for health professional postgraduate qualifications and licensing in Egypt.

What is the examination structure of the Egyptian Board in Family Medicine?

The examination comprises three standalone components: Part 1 (written MCQ examination in basic sciences, epidemiology, biostatistics, behavioral sciences, and clinical pharmacology, held in March and August); Part 2 (written MCQ examination in comprehensive clinical primary care, chronic diseases, maternal-child health, and UHIS guidelines, held in April and September); and Part 3 (clinical examination consisting of Objective Structured Clinical Examinations [OSCE], consultation skills, and clinical stations, held in December and January).

Does this question bank prepare candidates for Part 3 OSCE?

Part Three is a structured practical clinical examination (OSCE) assessing physical examination, procedural technique, and face-to-face consultation communication. This question bank is specifically designed as an English-language MCQ study aid for Part 1 and Part 2 written examination preparation.

How is the passing score determined for the written examinations?

The Egyptian Health Council uses criterion-referenced psychometric standard-setting methodologies (such as the Angoff, Modified Angoff, or Hofstee methods) to determine the cut score for each examination diet; no fixed arbitrary percentage pass mark is published.

What is the role of family medicine in Egypt's Universal Health Insurance System (UHIS)?

Under Law No. 2 of 2018, family physicians serving in accredited Primary Healthcare Units (PHUs) and Family Medicine Centers (FMCs) act as the mandatory first point of clinical contact and gatekeepers for beneficiary families, managing over 80% of healthcare needs and coordinating referrals to secondary and tertiary specialist facilities.